About Cellesce
Cellesce is a company based in Cardiff (United Kingdom) founded in 2013 was acquired by Molecular Devices in December 2022. The company has 9 employees as of March 31, 2021. Cellesce operates in a competitive market with competitors including Newcells Biotech, InSphero, Pandorum, Vivodyne and NextVivo, among others.
- Headquarter Cardiff, United Kingdom
- Employees 9 as on 31 Mar, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cellesce Limited
- Date of Incorporation 12 Apr, 2013
- Jurisdiction CARDIFF, WALES
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Gov.uk
& 4 more
-
Employee Count
9
as on Mar 31, 2021
-
Acquired by
Molecular Devices
(Dec 07, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Cellesce
Unlock access to complete
Unlock access to complete
Funding Insights of Cellesce
Investors in Cellesce
Cellesce has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, Development Bank of Wales and Molecular Devices.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of equity funding and business & property development loans
|
Locked | Locked | Locked | |
|
Sustainable business finance is provided for companies in Wales.
|
Locked | Locked | Locked | |
|
Online government services and information are provided to users.
|
Locked | Locked | Locked |
Investor details for Cellesce
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellesce
Investment portfolio details for Cellesce
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellesce
Detailed financials for Cellesce
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellesce Comparisons
Peer comparison for Cellesce
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellesce
Cellesce operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newcells Biotech, InSphero, Pandorum, Vivodyne and NextVivo, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| Locked | Locked | Locked |
Cell-based assays and 3D microtissues for drug screening are developed.
|
|
| Locked | Locked | Locked |
Regenerative medicine and 3D tissues are developed for therapeutic uses.
|
|
| Locked | Locked | Locked |
Developer of AI-based platform for lab-grown human tissues
|
|
| Locked | Locked | Locked |
Immune-competent human-derived models are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Provider of computational tools for bacterial metabolomic and genomic data analysis
|
Detailed competitors of Cellesce
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellesce
Complete news archive for Cellesce
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellesce
Cellesce was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Cellesce is headquartered in Cardiff, United Kingdom. It is registered at Cardiff, Wales, United Kingdom.
As of Mar 31, 2021, the latest employee count at Cellesce is 9.
Cellesce was founded in 2013 and is based in Cardiff, United Kingdom. Operations center on biotechnology, with a focus on scalable expansion of organoids for drug efficacy testing. These 3D structures replicate in vivo environments. The portfolio encompasses colorectal cancer organoids alongside those from other organs, supporting research applications.
Cellesce's top competitors include Newcells Biotech, InSphero and Vivodyne.
Cellesce has 5 investors. Key investors include Gov.uk, Development Bank of Wales, Molecular Devices, Development Bank of Wales, and NC3Rs.